top of page
야외 모임

Communication

Humedix and Exostemtech signed an agreement for joint development of exosome treatment


Humedix announced on the 5th that it has signed a business agreement with Exostemtech to develop exosome-based therapeutics and cosmetics.


Exostemtech is a domestic bioventure with technology for mass production, analysis and quality control of exosomes. He said that he has the original technology for an exosome-based protein drug delivery system. Based on stem cell exosomes, it is developing a treatment for degenerative arthritis, a treatment for liver fibrosis, and a treatment for lung fibrosis.


Recent Posts

See All

Comments


bottom of page